健康供精者精子染色质鱼精蛋白化与凝聚对ICSI结局的影响
回顾性研究分析健康供精者精子染色质鱼精蛋白化(CMA3)和凝聚能力(DBB)与ICSI结局的关系。双供组中CMA3与受精率相关,且不受女方年龄影响;两组的体外染色质凝聚能力均与囊胚率相关,独立于女方年龄。精子染色质鱼精蛋白化和凝聚还与妊娠及活产率相关,女方年龄可能是混杂因素。
要点
- 健康供精者精子鱼精蛋白化(CMA3)与双供组ICSI受精率相关。
- 精子体外染色质凝聚能力与两组囊胚率相关,独立于女方年龄。
- 精子染色质鱼精蛋白化和凝聚与妊娠及活产率相关,女方年龄为潜在混杂因素。
核心结论
- 精子染色质鱼精蛋白化与健康供精者ICSI受精率相关,精子体外染色质凝聚能力与囊胚率相关,两者关联在女方年龄<33岁时更明显。
研究设计与样本
- 回顾性研究,对精子染色质进行盲法分析,分为双供组(45例精液供者,55个ICSI周期,使用卵子捐赠者卵母细胞,年龄19-33岁,获得491枚胚胎)和单供组(34例精液供者,41个ICSI周期,使用健康女性卵母细胞,年龄20-44岁,获得378枚胚胎)。
主要发现
- 双供组解冻后0小时和4小时CMA3百分比分别为21.08±9.09和35.01±14.68,单供组分别为22.57±9.48和35.79±12.58。
- 双供组解冻后0小时和4小时DBB+百分比分别为16.57±11.10和10.51±8.40(P<0.0001),单供组分别为17.98±10.19和12.72±8.76(P<0.0001)。
- 双供组中CMA3与受精率相关(β1=-1.036,P<0.001),女方年龄无影响(β2=0.667,P=0.304);单供组中CMA3无显著关联(β1=-0.066,P=0.804),女方年龄有显著影响(β2=-1.451,P=0.003)。
- 精子体外染色质凝聚能力(%DBB+变化)与囊胚率相关,独立于女方年龄(双供组:β1=-0.238,P=0.008;β2=0.404,P=0.638;单供组:β1=-0.278,P=0.010;β2=-0.292,P=0.594)。
- 双供组中精子体外染色质凝聚能力还与胚胎达到囊胚阶段所需时间相关(P=0.007);多重逻辑回归显示染色质鱼精蛋白化和凝聚与卵子捐赠者及胚胎接受者年龄共同影响妊娠(P<0.01)和活产率(P<0.01)。
局限性
- 主要局限性是夫妇选择限制性较强,导致样本量相对较小,可能影响观察结果。
- 为减少I型错误,显著性水平设定为P≤0.01。
- 使用冷冻保存的样本也可能是一个局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do defects in sperm chromatin protamination and condensation have an impact on ICSI outcomes? SUMMARY ANSWER: Sperm protamination is related to fertilization rates in healthy donors, and the in vitro capacity of sperm to condense their chromatin is linked to blastocyst rates, both associations being more apparent in women <33 years of age. WHAT IS KNOWN ALREADY: Previous data on how sperm chromatin damage affects ICSI outcomes are inconsistent. Revealing which sperm factors influence embryo development is necessary to understand the male contribution to ICSI success and to develop novel sperm selection techniques or male-based treatments. Sperm chromatin is mainly condensed in protamines, which are cross-linked through disulphide bridges. This study aimed to determine whether sperm protamination and the integrity of disulphide bonds (condensation) are related to embryo development after ICSI. STUDY DESIGN, SIZE, DURATION: The design was a retrospective study with a blind analysis of sperm chromatin. Gametes were divided into two groups: double donation (DD) cohort and single donation (SD) cohort. Samples from 45 semen donors used in 55 ICSI cycles with oocyte donors (age range 19-33 years), generating 491 embryos, were included in the DD cohort. The SD cohort consisted of samples from 34 semen donors used in 41 ICSI cycles with oocytes from healthy females (single-parent families or lesbian couples, age range 20-44 years), generating a total of 378 embryos. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: Donor sperm samples from DD and SD cohorts were used for standard ICSI, and embryo development was observed by time-lapse imaging. The incidence of thiol reduction (dibromobimane, DBB) and the degree of chromatin protamination (chromomycin A3, CMA3, indicating non-protaminated regions) in sperm were determined by flow cytometry at 0 and 4 h post-thawing. MAIN RESULTS AND THE ROLE OF CHANCE: Percentages ± standard deviation of CMA3 were 21.08 ± 9.09 and 35.01 ± 14.68 at 0 and 4 h post-thawing, respectively, in the DD cohort and 22.57 ± 9.48 and 35.79 ± 12.58, at 0 and 4 h post-thawing, respectively, in the SD cohort. Percentages of DBB+ were 16.57 ± 11.10 and 10.51 ± 8.40 at 0 and 4 h post-thawing (P < 0.0001), respectively, in the DD cohort and 17.98 ± 10.19 and 12.72 ± 8.76 at 0 and 4 h post-thawing (P < 0.0001), respectively, in the SD cohort. Female age correlated with fertilization rates, and the relation between sperm chromatin and embryo development was determined through multiple linear regression. While CMA3 was associated with fertilization rates, with no influence of female age, in the DD cohort (β1 = -1.036, P < 0.001 for CMA3; β2 = 0.667, P = 0.304 for female age), this was not observed in the SD cohort, where female age had a significant effect, masking the effects of CMA3 (β1 = -0.066, P = 0.804 for CMA3; β 2 = -1.451, P = 0.003 for female age). The in vitro capacity of sperm to condense their chromatin after 4 h of incubation was associated with blastocyst rates, independent of female age (DD cohort: β1 = -0.238, P = 0.008 for %DBB+ variation; β2 = 0.404, P = 0.638 for female age; SD cohort: β1 = -0.278, P = 0.010 for %DBB+ variation; β2 = -0.292, P = 0.594 for female age). The in vitro capacity of sperm to condense their chromatin was also related to the time required for the embryo to reach blastocyst stage in the DD cohort (P = 0.007). Finally, multiple logistic regression showed that both chromatin protamination and condensation, together with the age of the oocyte donors and the embryo recipients, had an impact on pregnancy achievement (P < 0.01) and on live birth rates (P < 0.01). LIMITATIONS, REASONS FOR CAUTION: The main limitation was the restrictive selection of couples, which led to a relatively small sample size and could influence the observed outcomes. For this reason, and to reduce Type I error, the level of significance was set at P ≤ 0.01. On the other hand, the use of cryopreserved samples could also be a limitation. WIDER IMPLICATIONS OF THE FINDINGS: This research demonstrated that protamination and condensation of sperm chromatin are related to embryo development after ICSI, but female age could be a confounding factor when oocytes from older females are used. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the European Union's Horizon 2020 Research and Innovation scheme under the Marie Skłodowska-Curie grant agreement No 801342 (Tecniospring INDUSTRY; TECSPR-19-1-0003); La Marató de TV3 Foundation (214/857-202039); the Ministry of Science and Innovation, Spain (IJC2019-039615-I); the Catalan Agency for Management of University and Research Grants, Regional Government of Catalonia, Spain (2017-SGR-1229); and the Catalan Institution for Research and Advanced Studies, Spain (ICREA). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Ribas-Maynou J, Novo S, Salas-Huetos A, et al. Condensation and protamination of sperm chromatin affect ICSI outcomes when gametes from healthy individuals are used. Hum Reprod. 2023. PMID: 36539233. doi:10.1093/humrep/deac261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。